Pharma Company And Drug Testing Industry Claim Trump’s Rescheduling Move Will ‘Increase Marijuana Abuse’
A drug testing industry association and a pharmaceutical company are asking a federal court to block the Trump administration from moving forward with federal cannabis rescheduling while ongoing litigation challenging the reform is considered—arguing that “marijuana abuse has dangerous, lifelong consequences—especially for adolescents and pregnant women.” The new filing claims that “by cutting taxes on […]